Sitemap
Main Menu
- About MPLN
- Oncology Services
- Oncology Tests
- Breast Cancer
- Colorectal Cancer
- Dermatopathology
- Head and Neck Cancer
- Non Small Cell Lung Cancer
- Case Studies
- Gastroesophageal Junction Adenocarcinoma
- Myeloid Neoplasm with Eosinophilia and PDGFR-alpha Rearrangement
- Enteropathy-Associated T-cell Lymphoma
- BRAF V600E Mutation Positive Malignant Melanoma
- Acute Panmyelosis with Myelofibrosis
- Primary Colon Adenocarcinoma
- Malignant Plasma Cell Neoplasm
- Follicular Lymphoma (Grade 3) Arising within Hashimoto's Thyroiditis
- Companion Diagnostics
- Targeted Therapy
- Women's Health
- Pathology Partners
- Billing
- News
- Pathology Top Picks
- Molecular Mutation Status Identifies Prognostically Significant Risk Groups in AML
- Differentiating Breast Cancer Metastases from Sweat Gland Carcinomas
- Extending Storage and Fixation Requirements for HER2 Testing
- New Classification for Pulmonary Adenocarcinoma, Association with EGFR Mutations
- ALK Gene Copy and Amplification Frequency Increased in NSCLC
- Leukemia-Associated Genetic Changes Found in Normal Blood
- 100 Cases of Mixed Phenotype Acute Leukemia Documented
- Molecular Analysis of Thyroid Tumor FNAs Useful for Prognosis
- Oncology News
- Congress passes $300m fund increase for NIH and CDC programs
- Phase I data suggest potential new treatment for MPN
- ER PR Status, Regular Biopsies Needed for Appropriate Treatment
- FDA Approves Crizotinib Therapy for ALK-Positive NSCLC
- p16 Stratifies HPV Risk in Head and Neck Squamous Cancer
- BRAF Mutation in Hairy-Cell Leukemia Paving the Way for Targeted Therapy
- Improved Survival with Vemurafenib for Melanoma with BRAF Mutation
- CTC Count Is 'Powerful Predictor' of Cancer Treatment Assessment
- Study Shows Positive Outcomes for CML Treatment with Imatinib
- Advanced Tests Assist Physicians in Fight Against Colorectal Cancer
- BRAF V600 Mutation Target of New Melanoma Therapy
- Thrombosis Risk Rises in Women with Myeloproliferative Disorder
- Interpretation of Laboratory Testing for Pulmonary Sarcoidosis
- SUCCESS Trial Focuses on CTCs
- Study Shows Data on Trastuzumab-DM1 in Breast Cancer Treatment
- Study May Explain Loss of Lenalidomide Effectiveness in MDS
- Identifying BRAF Mutation Assists in Targeted Metastatic Melanoma Therapy
- NCCN Receives $2 Million Grants for Cancer Treatment Studies
- Nilotinib Receives Front-Line Treatment Approval for CML
- US Cancer Death Rates Declining
- Targeted Therapy for NSCLC Creates Stir at ASCO
- HER2 Retesting Could Predict Treatment Effectiveness
- Breast Cancer Receptor Interaction May Impact Therapy
- FDA Approves Rituximab in Combination with Other Therapies for Untreated CLL
- Herceptin Approved for HER2-positive Gastric Cancer
- ACS Offers Online Cancer Support For Families
- Study Correlates KRAS Mutation with Colorectal Liver Metastases
- MPLN Offers Epstein-Barr by ISH
- HER2 Testing Utilization Under Review
- Study Confirms Genes Determine Patient Response to Warfarin
- Study Forecasts Savings for Marker-Based Cancer Treatment
- ASCO Urges KRAS Gene Testing for Colorectal Cancer
- Case Studies
- Gastroesophageal Junction Adenocarcinoma
- Myeloid Neoplasm with Eosinophilia and PDGFR-alpha Rearrangement
- Enteropathy-Associated T-cell Lymphoma
- BRAF V600E Mutation Positive Malignant Melanoma
- Acute Panmyelosis with Myelofibrosis
- Primary Colon Adenocarcinoma
- Malignant Plasma Cell Neoplasm
- Follicular Lymphoma (Grade 3) Arising within Hashimoto's Thyroiditis
- Women's Health News
- Guideline Updates
- CMS Will Not Enforce Physician-Signature Rule on Requisitions
- CDC Publishes New Diagnosis and Treatment Guidelines for STDs
- NCCN Offers New Patient Guidelines for Breast and Non-Small Cell Lung Cancer
- Experts Issue New Guidelines on Breast Cancer Drugs
- Study Finds Some PCPs Not Following Cervical Cancer Screening Guidelines
- NCCN Guidelines Include BRAF Testing
- Company News
- MPLN Offers Valuable Tests to Fight Breast Cancer Every Month
- Indigo provides on-line status for ordered tests
- Dr. Jitakshi De Joins Hematopathology Team at MPLN
- Study Supports the Use of Cervista HPV 16/18 Genotyping Test
- Quigley, Potter Co-Author Article Comparing Two HPV Assays
- MPLN Among First to Offer Gen-Probe Trichomonas Vaginalis Assay
- Dr. Nicholas Potter Named Guest Speaker at Diagnostic Summit
- Dr. Nichols Among Faculty of Practical Reviews in Pathology
- Webb-Martin Co-Authors Abstract on International BCR/ABL Study
- Ajenda Wins ICCS Logo Competition
- MPLN Connects With Clients, Community Using New Media
- Quigley Co-Authors Article on Cervical Cancer and HPV
- Client Services Has New Number
- MPLN Celebrates Laboratory Professionals
- MPLN Website Earns Marketing Award
- Nichols Named Chief Medical Officer
- Dr. Potter Publishes Article on Colorectal Cancer Testing
- Ajenda Healthcare Marketing Launches New Website
- Seabrook Named ACS Advocacy Chair
- Screenings Vital For Early Detection of Breast Cancer
- MPLN Division Granted Trademark Registration
- Strategic Approach to Cancer Management Saves Time and Money
- MPLN Launches New Website
- MPLN Celebrates 20 Years
- Lowe Named Field Support Specialist
- Geneuity Wins Third Diagnostic Marketing Award
- Dr. Quigley Co-Authors Article on BCR-ABL
- Geneuity Wins Diagnostic Marketing Award
- MPLN Wins Innovator Award
- Musick Named Field Support Specialist
- Congress passes $300m fund increase for NIH and CDC programs
- Phase I data suggest potential new treatment for MPN
- ER PR Status, Regular Biopsies Needed for Appropriate Treatment
- FDA Approves Crizotinib Therapy for ALK-Positive NSCLC
- p16 Stratifies HPV Risk in Head and Neck Squamous Cancer
- BRAF Mutation in Hairy-Cell Leukemia Paving the Way for Targeted Therapy
- Improved Survival with Vemurafenib for Melanoma with BRAF Mutation
- CTC Count Is 'Powerful Predictor' of Cancer Treatment Assessment
- Study Shows Positive Outcomes for CML Treatment with Imatinib
- Advanced Tests Assist Physicians in Fight Against Colorectal Cancer
- BRAF V600 Mutation Target of New Melanoma Therapy
- Thrombosis Risk Rises in Women with Myeloproliferative Disorder
- Interpretation of Laboratory Testing for Pulmonary Sarcoidosis
- SUCCESS Trial Focuses on CTCs
- Study Shows Data on Trastuzumab-DM1 in Breast Cancer Treatment
- Study May Explain Loss of Lenalidomide Effectiveness in MDS
- Identifying BRAF Mutation Assists in Targeted Metastatic Melanoma Therapy
- NCCN Receives $2 Million Grants for Cancer Treatment Studies
- Nilotinib Receives Front-Line Treatment Approval for CML
- US Cancer Death Rates Declining
- Targeted Therapy for NSCLC Creates Stir at ASCO
- HER2 Retesting Could Predict Treatment Effectiveness
- Breast Cancer Receptor Interaction May Impact Therapy
- FDA Approves Rituximab in Combination with Other Therapies for Untreated CLL
- Herceptin Approved for HER2-positive Gastric Cancer
- ACS Offers Online Cancer Support For Families
- Study Correlates KRAS Mutation with Colorectal Liver Metastases
- MPLN Offers Epstein-Barr by ISH
- HER2 Testing Utilization Under Review
- Study Confirms Genes Determine Patient Response to Warfarin
- Study Forecasts Savings for Marker-Based Cancer Treatment
- ASCO Urges KRAS Gene Testing for Colorectal Cancer
- Pathology Top Picks
- Specimen Logistics
Follow MPLN
Testing Links
| Test Menu |
| Online Ordering |
| Requisitions and Forms |
| Make a Payment |